In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
Results from a retrospective study in Lancet Neurology reveal that high concentrations of neurofilament light proteins (NfLs) in blood plasma of HTT gene mutation carriers can predict clinical…
Although HCV-related cirrhotic patients can achieve a sustained virological response (SVR) to IFN-based anti-HCV therapy, the risk of cirrhosis regression and liver cancer may still exist. A long-term…
Known as "xiao qiang" in China, or the "little mighty,” the American cockroach’s recent genome sequencing may help us understand how it earned that nickname.
Hepatitis C (HCV) infects an estimated 150 million people worldwide. It has proven to be a major cause of concern for medical professionals since it can also lead…
Professor Peter Jennings, BPharm, PhD, DSc, at Kings College of London discussed the most promising treatments out there right now for combating Parkinson’s. He discussed the condition to…
According to Lars Brouwers, MD, MSc, a physician and PhD-candidate performing research on 3D-printing in the hospital environment, when doctors use traditional x-ray and 2DCT diagnostic tools in…
